Buoyed by strategic brand exits and tariff mitigation, Church & Dwight enters 2026 with robust cash flow and a sharpened focus on its 'power brands' like Arm & Hammer and TheraBreath, despite a challenging consumer landscape.
Consumer staples giant Church & Dwight (NYSE:CHD) reported fourth-quarter revenue in line with Wall Street expectations, though underlying organic sales showed signs of stagnation. The company's gross margin outperformance provided a bright spot, lifting shares post-earnings.
Federal authorities have arrested two additional individuals tied to a January protest at a Minnesota church, reigniting debate over the use of a novel conspiracy charge and the arrest of journalist Don Lemon, who was recently released by a magistrate.
The trial of four men charged with the murder of Michelle Sadio, a mother of two killed outside a Harlesden church in 2024, has begun, revealing allegations of a botched attack targeting a local rapper.
A recent restoration of a church fresco in central Rome has drawn scrutiny and amusement after a national newspaper pointed out the angel's new face bears a striking likeness to Prime Minister Giorgia Meloni, prompting a ministry investigation.
Florida Attorney General Pam Bondi forcefully rebutted First Amendment criticisms following the arrests of ex-CNN anchor Don Lemon and several activists at a St. Paul church, framing the incident as a dangerous disruption that terrorized worshippers and vowing full prosecution.
Shares of consumer goods giant Church & Dwight (CHD) climbed nearly 5% following the release of strong annual results and an optimistic sales forecast, coupled with its 30th consecutive annual dividend increase.
Victims of Jeffrey Epstein have condemned the Justice Department's release of over 3 million pages of documents as a retraumatizing and incomplete disclosure that exposes survivors while shielding alleged abusers, prompting bipartisan calls for full transparency.
A deep dive into the bullish investment thesis for American Resources Corporation (AREC), which hinges on its proprietary rare earth processing technology and a pivotal $1.4 billion U.S. government partnership aimed at reducing reliance on China.
TotalEnergies has fully restarted its massive Mozambique LNG project and solidified its position in Namibia's Orange Basin, signaling a major strategic push into African natural gas. While promising long-term growth, the moves prompt fresh scrutiny over project valuations and execution risks in emerging markets.
Walmart stock jumped over 4% Monday as a new trade agreement between the U.S. and India promises lower tariffs and increased market access, bolstering the retail giant's strategic pivot toward Indian manufacturing and e-commerce.
Meta Platforms is hit with a patent infringement lawsuit by Solos Technology, targeting core components of its smart glasses. The legal challenge could disrupt product development and partnerships in a key growth area for the tech giant.
Apple shares surged over 4% as blockbuster Q1 earnings, led by iPhone sales and services growth, reignited investor confidence in the tech giant's expansion narrative, particularly in key markets like India.
Elon Musk merges his rocket company with his AI startup, arguing that the future of scalable artificial intelligence depends on moving its immense power demands off-planet.
As new CEOs take the helm at Target and Walmart, the retailers face divergent paths—one battling slumping sales and investor flight, the other riding a wave of growth fueled by e-commerce and high-income shoppers.
Private equity firm RoundTable Healthcare Partners has acquired the dermatologist-trusted skincare and sun protection brand Colorescience from 1315 Capital, as the company's annual sales approach the $100 million mark.
Ed Martin, a staunch Trump loyalist appointed to lead a Justice Department group scrutinizing prosecutors who investigated the former president, has been removed from that position, sources confirm. He remains in his separate role as Pardon Attorney.
Ed Martin, a controversial Trump appointee, has been ousted from his role leading the Justice Department's 'Weaponization Working Group' following internal clashes and scrutiny over his conduct, though he remains in a separate advisory position.
T-Mobile has filed a WARN notice with Washington state officials, signaling permanent layoffs for 393 employees across multiple locations starting April 2026, amid a broader wave of tech sector workforce reductions.
New clinical imaging data for Molecular Partners' experimental radiotherapeutic MP0712, targeting the DLL3 protein in cancers like small cell lung cancer, show favorable tumor targeting and healthy organ clearance. The company confirms its U.S. Phase I/II trial is now open for patient screening.
